1. Home
  2. RDHL vs XELB Comparison

RDHL vs XELB Comparison

Compare RDHL & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • XELB
  • Stock Information
  • Founded
  • RDHL 2009
  • XELB 2011
  • Country
  • RDHL Israel
  • XELB United States
  • Employees
  • RDHL N/A
  • XELB N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • RDHL Health Care
  • XELB Miscellaneous
  • Exchange
  • RDHL Nasdaq
  • XELB Nasdaq
  • Market Cap
  • RDHL 4.3M
  • XELB 4.6M
  • IPO Year
  • RDHL N/A
  • XELB N/A
  • Fundamental
  • Price
  • RDHL $2.18
  • XELB $1.70
  • Analyst Decision
  • RDHL
  • XELB
  • Analyst Count
  • RDHL 0
  • XELB 0
  • Target Price
  • RDHL N/A
  • XELB N/A
  • AVG Volume (30 Days)
  • RDHL 17.8K
  • XELB 99.2K
  • Earning Date
  • RDHL 08-28-2025
  • XELB 08-13-2025
  • Dividend Yield
  • RDHL N/A
  • XELB N/A
  • EPS Growth
  • RDHL N/A
  • XELB N/A
  • EPS
  • RDHL N/A
  • XELB N/A
  • Revenue
  • RDHL $8,042,999.00
  • XELB $7,407,000.00
  • Revenue This Year
  • RDHL $381.91
  • XELB $23.96
  • Revenue Next Year
  • RDHL N/A
  • XELB $53.02
  • P/E Ratio
  • RDHL N/A
  • XELB N/A
  • Revenue Growth
  • RDHL 23.17
  • XELB N/A
  • 52 Week Low
  • RDHL $1.71
  • XELB $1.51
  • 52 Week High
  • RDHL $20.28
  • XELB $8.49
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 65.22
  • XELB 39.57
  • Support Level
  • RDHL $2.00
  • XELB $1.51
  • Resistance Level
  • RDHL $2.08
  • XELB $1.80
  • Average True Range (ATR)
  • RDHL 0.09
  • XELB 0.13
  • MACD
  • RDHL 0.03
  • XELB 0.01
  • Stochastic Oscillator
  • RDHL 97.73
  • XELB 30.58

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: